APL is a leading Scandinavian contract manufacturer within the Life science sector with resources for development, manufacturing and analysis of pharmaceuticals. APL is also one of Europe's largest manufacturers of extemporaneous pharmaceuticals. APL has an annual turnover of about 150 M€ and 550 employees at four production facilities in Sweden and also at preparation units at hospitals. APL contributes to pharmaceuticals which improve and save lives.
Biognos AB is a company specialized in computational drug design. Biognos provides services in virtual screening (ligand-based and structure-based) and also structure-based lead optimization. We are offering these services primarily to pharmaceutical and biotech companies which do not have sufficient in-house modelling facilities. We also provide the services to academic groups working e.g. in the field of chemical biology. Biognos also works on some in-house projects in collaboration with academic research groups.
Provides medical writing services to pharmaceutical companies and others working in biomedical research.
Regarding Horizon 2020 and other types of public innovation funding GAEU Consulting is the market leading EU grant consultancy firm in Sweden. Every year we produce a huge number of high quality grant applications (e.g. SME Instrument applications for Immunovia (granted 4,25M€) and Clinical Laserthermia Systems (granted 2,1M€)). Our expertise is concentrated in Europe's largest private knowledge hub for EU funding, the GAEU Horizon 2020 Center of Excellence. Reference list on www.gaeu.se
ImCred Patent AB is a consultancy company specialized in intellectual property (IP) matters within the life science area. ImCred Patent provides advise with a heavy focus on IP-strategy and the US patent law, particularly IP-matters in the interface between patent laws and regulatory laws. The Company was founded 2010 by Ann-Sofie Sternås. In addition to its own competence, ImCred Patent can offer a global network of top-quality IP lawers, investors and CRO´s.
The company provides consulting service to the pharmaceutical industry in the areas of Regulatory Affairs and drug development strategy. The service includes regulatory activities and strategy, advice on development plans and planning/preparation of clinical trial application within drug development.
With 25 years of experience and long standing connections with key journalists, we are passionate about helping small and medium-size life science companies with exciting innovations to succeed. We have the skills to provide PR service to support a company regardless of whether the goal is to secure financing, out-license the technology, find a partner or support marketing in the market place. Where we stand out as different is how we ensure that journalists pick up the story from their incoming news flow.
MediGelium AB provides services within the specialist fields of liquid and semisolid pharmaceutical formulations and applied surface and colloid chemistry, as well as services related to the filing of new patent applications on novel formulations.
Merck is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative, performance products, services and business relationships that enable our customers’ success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, Merck serves as a strategic partner to customers and helps advance the promise of life science.
Scandinavian Development Services is a Swedish consultancy company focused on Drug Development and Biostatistics. Our services include advise on CMC questions, non-clinical and clinical programs, regulatory affairs, medical writing, trial design and biostatics. We can provide the right level of support for most projects, minor isolated tasks or full project management. Our consultants have extensive experience from the pharmaceutical industry with hands on experience bringing products to market or exit.